GlucoTrack announces completion of first in human clinical study of CGM

Glucotrack (GCTK) announced the successful completion of its first in human clinical study, marking a significant milestone in continuous glucose monitoring, CGM. This study represents the first real-time, continuous blood glucose monitor placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations often seen with traditional continuous glucose monitors that measure glucose levels in interstitial fluid.